EXPERT OPINION ON THERAPEUTIC TARGETS

期刊基本信息

期刊名称：EXPERT OPINION ON THERAPEUTIC TARGETS

出版国家或地区：ENGLAND

是否OA：No

期刊ISSN：1472-8222

期刊官方网站：http://www.tandfonline.com/loi/iett20#.V48c20z9cSQ

期刊投稿网址：https://mc.manuscriptcentral.com/eott

通讯方式：INFORMA HEALTHCARE, TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON, ENGLAND, EC2A 4LQ

涉及的研究方向：医学-药学

出版周期：Monthly

出版年份：2001

期刊数据表：

EXPERT OPINION ON THERAPEUTIC TARGETS英文简介：

Published by Informa Pharmaceutical Science (formerly Ashley Publications). ISSN: 1472-8222.Expert Opinion on Therapeutic Targets is the premier journal dedicated to in-depth reports and reviews of the latest developments in the field of drug target discovery and validation. Expert Opinion on Therapeutic Targets is a peer-reviewed journal providing evaluated and expert reviews of recent research identifying novel molecular drug targets. The journal provides an essential link between basic research on biological pathways and interactions, and the development of the drugs of tomorrow. It is distinguished from other publications by its high-quality authorship and expertly drafted articles which are structured to incorporate the author's own expertise on the subject. The audience consists of scientists, managers and decision makers in the pharmaceutical industry, and others closely involved in R&D. Subscribers include most of the major pharmaceutical companies in the USA, Europe and Japan, as well as many biotechnology companies.

EXPERT OPINION ON THERAPEUTIC TARGETS中文简介：

由Informa Pharmaceutical Science出版(原Ashley Publications)。ISSN: 1472 - 8222。《治疗靶标的专家意见》是一本致力于深入报道和评论药物靶标发现和验证领域最新进展的权威杂志。《治疗靶标的专家意见》是一份同行评议的期刊，提供对最近发现新的分子药物靶标的研究的评估和专家评议。该杂志提供了生物途径和相互作用的基础研究与未来药物开发之间的重要联系。它与其他出版物的不同之处在于其高质量的作者和专业起草的文章，这些文章的结构吸收了作者自己在这个问题上的专业知识。观众包括制药行业的科学家、经理和决策者，以及与研发密切相关的其他人。用户包括美国、欧洲和日本的大多数主要制药公司，以及许多生物技术公司。

EXPERT OPINION ON THERAPEUTIC TARGETS在线问答：